Copyright
©The Author(s) 2024.
World J Diabetes. Dec 15, 2024; 15(12): 2293-2301
Published online Dec 15, 2024. doi: 10.4239/wjd.v15.i12.2293
Published online Dec 15, 2024. doi: 10.4239/wjd.v15.i12.2293
Table 1 Symptoms and grades of iodine contrast extravasation
Symptom | Grade |
No obvious symptoms | 0 |
Edema diameter < 2.54 cm | 1 |
2.54 cm < edema diameter < 15.24 cm | 2 |
Translucent edema (diameter > 15.24 cm) | 3 |
Edema diameter > 15.24 cm, combined with blood oozing, circulatory disturbance, and moderate to severe pain | 4 |
Table 2 Contrast-enhanced computed tomography imaging quality grading
Image | Grade |
Clear vascular display and no artifacts or only a few artifacts, which does not affect the diagnosis | Good |
Blurred development of important blood vessels or interrupted display of blood vessels, with a large number or all artifacts in arteries, which cannot be used for diagnosis | Poor |
Table 3 Comparison of general information, n (%)
| Control group (n = 102) | Research group (n = 102) | χ2/t | P value |
Sex | 0.316 | 0.574 | ||
Male | 53 (51.96) | 57 (55.88) | ||
Female | 49 (48.04) | 45 (44.12) | ||
Age (years) | 59.68 ± 11.82 | 61.41 ± 12.92 | 0.995 | 0.321 |
Cancer type | 2.487 | 0.288 | ||
Lung cancer | 43 (42.16) | 35 (34.31) | ||
Colorectal cancer | 39 (38.24) | 38 (37.25) | ||
Gastric cancer | 20 (19.61) | 29 (28.43) | ||
Underlying diseases | ||||
Hypertension | 0.179 | 0.673 | ||
With | 55 (53.92) | 58 (56.86) | ||
Without | 47 (46.08) | 44 (43.14) | ||
Coronary heart disease | 0.666 | 0.186 | ||
With | 38 (37.25) | 41 (40.20) | ||
Without | 64 (62.75) | 61 (59.80) | ||
Puncture site | 0.766 | 0.682 | ||
Median cubital vein | 14 (13.73) | 11 (10.78) | ||
Basilic vein | 84 (82.35) | 85 (83.33) | ||
Cephalic vein | 4 (3.92) | 6 (5.88) | ||
Long-term chemotherapy | 0.091 | 0.763 | ||
With | 69 (67.65) | 71 (69.61) | ||
Without | 33 (32.35) | 31 (30.39) |
Table 4 Occurrence of iodine contrast extravasation during computed tomography scanning, n (%)
Control group (n = 102) | Research group (n = 102) | χ2 | P value | |
No extravasation | 95 (93.14) | 101 (99.02) | ||
Mild extravasation | 4 (3.92) | 1 (0.98) | ||
Moderate extravasation | 1 (0.98) | 0 (0.00) | ||
Severe extravasation | 2 (1.96) | 0 (0.00) | ||
Incidence of extravasation | 7 (6.86) | 1 (0.98) | 4.684 | 0.031 |
Table 5 Adverse events in the two groups, n (%)
Control group (n = 102) | Research group (n = 102) | χ2 | P value | |
Discomfort | 5 (4.90) | 3 (2.94) | ||
Redness and swelling at the puncture site | 2 (1.96) | 1 (0.98) | ||
Blood oozing | 4 (3.92) | 3 (2.94) | ||
Incidence rate of adverse events | 11 (10.78) | 7 (6.86) | 0.975 | 0.324 |
Table 6 Imaging quality of contrast-enhanced computed tomography scanning, n (%)
Control group (n = 102) | Research group (n = 102) | χ2 | P value | |
4.300 | 0.038 | |||
Good | 87 (85.29) | 96 (94.12) | ||
Poor | 15 (14.71) | 6 (5.88) |
Table 7 The intubation time, number of venipuncture attempts, intubation success rate, and catheter maintenance cost of the two groups, n (%)
Control group (n = 102) | Research group (n = 102) | χ2/t | P value | |
Number of venipuncture attempts | 2.21 ± 0.78 | 1.49 ± 0.58 | 7.486 | 0.000 |
Success intubation | 38.570 | 0.000 | ||
Yes | 17 (16.67) | 60 (58.82) | ||
No | 85 (83.33) | 42 (41.18) | ||
Catheter maintenance cost after 6 months (CNY) | 1251.79 ± 205.47 | 1019.25 ± 117.28 | 9.927 | 0.000 |
- Citation: Zhang L, Yan HF. Application value of high-pressure-resistant peripherally inserted central catheters in enhanced computer tomography of diabetic patients with malignant tumors. World J Diabetes 2024; 15(12): 2293-2301
- URL: https://www.wjgnet.com/1948-9358/full/v15/i12/2293.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i12.2293